• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.22% Nasdaq Up 2.00%

    Novavax, Inc. (NVAX)

    -NasdaqGS
    5.50 Up 0.14(2.61%) May 24, 4:00PM EDT
    |Pre-Market : 5.96 Up 0.46 (8.36%) 8:49AM EDT - Nasdaq Real Time Price
    Prev Close:5.36
    Open:5.44
    Bid:5.95 x 5000
    Ask:5.97 x 5000
    1y Target Est:14.21
    Beta:1.82711
    Earnings Date:Aug 8 - Aug 12 (Est.)
    Day's Range:5.37 - 5.52
    52wk Range:4.08 - 15.01
    Volume:4,427,072
    Avg Vol (3m):5,689,440
    Market Cap:1.49B
    P/E (ttm):N/A
    EPS (ttm):-0.78
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVAXUp 2.61%1.49B
    MRKUp 1.24%153.90B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):47.44
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.96
    Quarterly EPS Est (Jun-16) :-0.25
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback